Prediction of Tongue Base Obstruction During Sleep
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Jan 19, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the movement of the tongue in children can help predict where and how severe the blockage in their airway is during sleep. This is important because some children experience obstructive sleep-disordered breathing, which can lead to serious health issues and may require surgery to remove tonsils or adenoids. The researchers believe that understanding tongue function could help identify the best treatment options for these children.
To be eligible for this study, children must be between 6 and 17 years old and have a medical diagnosis of obstructive sleep-disordered breathing that requires surgical treatment. They also need to have a score of 8 or more on a pediatric sleep questionnaire, indicating significant sleep issues. Children with certain other medical conditions, previous surgeries in the upper airway, or specific head or neck problems will not be able to participate. Those who join the trial can expect to undergo assessments that will help determine their airway obstruction, which could lead to better treatment for their sleep issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 6 and 17 years old
- • Medical diagnosis of obstructive sleep-disordered breathing requiring surgical removal of tonsils (partial or total) and/or adenoids
- • Positive Pediatric Sleep Questionnaire (8 or more positive responses)
- • Eligibility for surgical intervention
- Exclusion Criteria:
- • Neurological, cardiac, or respiratory comorbidity other than obstructive sleep-disordered breathing
- • Previous surgery of the upper airway or oral cavity
- • History of or current head or neck cancer
- • Cranial, upper airway, or oral cavity malformation
- • Contraindication to performing endoscopy
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported